[ Methylpiperazine-11C]brigatinib

N/A

Report date: 2023/08/31 18:02:34
NME

Base Information

Drug Name[ Methylpiperazine-11C]brigatinib
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsAnaplastic lymphoma kinaseEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVrije Universiteit Amsterdam
China Registration ClassN/A

Develop Information

Active CompaniesVrije Universiteit Amsterdam
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A